SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

IDF faces strain as missile stocks dwindle amid continued conflict

The AI revolution: From private use to business growth

Venn secures multi-million dollar contract with Bozzuto, expands US footprint

Israel tests cutting-edge drone interception systems to counter evolving threats

Buzz

Most popular

Daily

Weekly

1

Intel pushes layoffs of hundreds of employees in Israel to end of October

2

Pickommerce raises $3.4M to upgrade warehouses with robotic piece-picking solution

3

Port raises $35 million Series B as demand for DevOps solutions soars

4

Israeli entrepreneurs lead the charge as Miami emerges as a new tech and investment hub

5

Venture capitalists turn Miami into a hub for Israeli startups

Copaxone

4 stories about Copaxone

חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer

A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug

Teva Loses Copaxone Market Exclusivity

04.10.17|Lilach Baumer

Rival Mylan received FDA approval for its generic versions of Copaxone, Teva’s flagship drug

מנכ"ל טבע החדש קור שולץ 2

New CEO to Break Teva’s Copaxone Habit

11.09.17|Sophie Shulman, Dror Reich

Troubled drugmaker says new CEO must work to quickly regain its financial credibility

תרופות טבע גלולות תרופה

With Bloated Debt, Teva Looks to Sell Assets

10.08.17|Eli Shimony and Gil Kalian

The generic drugmaker said it is looking to sell Medis, an Iceland-based company it bought in 2016

Previous Articles